TruScreen signs up another Chinese cancer screening programme

TruScreen signs up another Chinese cancer screening programme
Sophie Boot
By Sophie Boot May 31 (BusinessDesk) - TruScreen, the NZAX-listed cervical cancer test developer, will have its technology used in a major cervical cancer screening programme in north-eastern China. The programme will screen 160,000 women in Heilongjiang province over the next 18 months, under the control of the Provincial Cancer Hospital of Heilongjiang which is located in the province's largest city, Harbin, the company said in a statement. It is funded by the Harbin division of the All China Federation of Trade Unions (ACFTU). "Prov...